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Hepatic Effects of Phthalate Esters and
Related Compounds-In Vivo and In Vitro
Correlations*
by Brian G. Lake,t Tim J. B. Gray,t and Sharat D. Gangollit
The hepatic effects of phthalate esters and related compounds on peroxisomal and microsomal enzyme
activities were investigated in the intact animal and in primary hepatocyte cultures. In vitro studies with
a series ofphthalate monoesters demonstrated structure activity differences in the induction ofthe specific
peroxisomal marker KCN-insensitive palmitoyl-CoA oxidation and also of carnitine acetyltransferase.
These effects could be reproduced in vivo, and potency differences were also observed between di(2-
ethylhexyl) phthalate (DEHP) and its straight-chain isomer, di-n-octyl phthalate. In in vivo studies,
DEHP, mono(2-ethylhexyl) phthalate, and clofibrate/clofibric acid produced large increases in liver size
and peroxisomal enzyme activities in Sprague-Dawley rats and Chinese hamsters, but had less effect in
Syrian hamsters. These effects could be largely reproduced in vitro where good responses were obtained
with rat and Chinese hamster hepatocytes, but either little or no effect with Syrian hamster and Dunkin-
Hartley guinea pig hepatocytes. Both DEHP and clofibrate appeared to induce similar form(s) of micro-
somal cytochrome P-450 which exhibited a high specificity towards lauric acid hydroxylation. With arange
of hypolipidemic agents, including phthalate monoesters, a good correlation was observed between the
induction ofperoxisomal and microsomal enzyme activities in rat hepatocyte cultures. These results thus
demonstrate a good relationship between the in vivo and in vitro effects of phthalate esters and related
compounds and suggest that hepatocyte cultures may be useful for further studies on the hepatic effects
of peroxisome proliferators.
Introduction
A number of compounds are known to produce liver
enlargement and hepatic peroxisome proliferation in ro-
dents and certain of these compounds have also been
found to increase the incidence of liver tumors in rats
and/or mice (1,2). Although the precise relationship be-
tween peroxisome proliferation and tumorformation re-
mains to be established, it has been suggested that per-
oxisome proliferators constitute a novel class of
chemical carcinogens (2,3). The phthalate ester plasti-
cizer di(2-ethylhexyl) phthalate (DEHP) has also been
shown to produce liver enlargement and hepatic per-
oxisome proliferation in rats (4,5) and mice (6) and to
increase the incidence of liver tumors in these two spe-
cies (7).
Apart from increasingperoxisomal enzyme activities,
and in particular the enzymes of the peroxisomal fatty
acid ,B-oxidation cycle (8), certain peroxisome prolifer-
ators are known to enhance the microsomal oxidation
offatty acids (9). Indeed, Gibson and co-workers (10,11)
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have isolated a novel form of cytochrome P-450 from
the livers of clofibrate [ethyl 2-(p-chlorophenoxy) iso-
butyrate] treated rats which has a high specificity for
the w- and (w - 1)-hydroxylation of lauric acid, but cor-
respondingly low specificity towards typicalmixed func-
tion oxidase substrates. Both DEHP and clofibrate also
induce cytosolic epoxide hydratase and glutathione S-
transferase activity in rodent liver (12).
We have been interested in elucidating the hepatic
effects ofphthalate esters both in the intact animal and
in vitro employing primary hepatocyte cultures. Using
these systems we have investigated the structure ac-
tivityrequirementsforinduction ofperoxisomal enzyme
activitiesbyphthalate esters. Theeffects onmicrosomal
enzyme activities have also been determined. Finally,
as species differences may be important in assessingthe
relevance of the rat and mouse carcinogenicity studies
(7) to man we have also examined the effect of DEHP
and other peroxisome proliferators in the rat, Syrian
and Chinese hamsters.
Materials and Methods
Materials
Samples ofmono-n-octyl, mono(1-ethylhexyl), mono-
(2-ethylhexyl), mono-n-hexyl, mono(1-ethylbutyl),LAKE, GRAY, AND GANGOLLI
mono(2-ethylbutyl) and monoethyl phthalates were syn-
thesized by the method ofAlbro et al. (13) for phthalate
monoesters. Their purity was established by thin layer
chromatography, nuclear magnetic resonance spectros-
copy and by elemental analysis. DEHP (99.5% pure)
was the generous gift of BP Chemicals Ltd., Sully,
South Glamorgan, Wales, U.K. All other peroxisome
proliferators, enzyme substrates and cofactors and tis-
sue culture materials were obtained from the sources
cited previously (14-17).
Animals and Treatment
Male animals were used forall studies. Sprague-Daw-
ley rats (100-120 g) were purchased from Olac (1976)
Ltd., Blackthorn, Bicester, Oxon, U.K., and Dunkin-
Hartley guinea pigs (400-450 g) from Porcellus Animal
Breeding Ltd., Heathfield, East Sussex, U.K. Syrian
hamsters (70-80 g) were obtained from Intersimian
Ltd., Milton Trading Estate, Milton, Oxon, U.K., and
Chinese hamsters (20-25 g) from Bantin and Kingman
Ltd., Grimston, Hull, U.K. The animals were housed
in rooms maintained at 22 + 3°C with a relative hu-
midity of40-70% and allowed free access to appropriate
laboratory animal diets and water. After acclimatizing
to these conditions for 7 days, the animals were treated
with the phthalate esters and related compounds at the
dose levels described in the text by daily gastric intu-
bation for either 7 or 14 days. Control animals received
corresponding quantities (5 mL/kg) of the corn oil ve-
hicle. Following the last dose, the animals were starved
overnight, killed by cervical dislocation and the livers
immediately excised for biochemical studies. Whole
liver homogenates (0.25 g fresh tissue/mL) were pre-
pared in 0.154 M KCl containing 50 mM Tris-HCl pH
7.4, employing a Potter-type, Teflon-glass, motor-
driven homogenizer (15).
Hepatocyte Isolation and Culture
Hepatocytes were obtained from rats, hamsters, and
guinea pigs by a collagenase perfusion technique de-
scribed previously (14); 2.5 x 106 viable cells were
seeded in 60 mm tissue culture plates in 3 mL RPMI
1640 medium containing 5% fetal calf serum, 50 Rg/mL
gentamicin, 1 FM insulin, and 0.1 mM hydrocortisone-
21-sodium succinate. Cultures were maintained at370C
in 5% C02/95% air and after 2 hr treatment was com-
menced by replacing the medium with either medium
containing 0.4% (v/v) dimethyl sulfoxide (control cul-
tures) or medium containing the test compounds dis-
solved in dimethyl sulfoxide (test cultures). Subse-
quently the medium was changed and the cells redosed
every 24 hr. After 70hrthe hepatocytes were harvested
in 0.154 M KCl containing 50 mM Tris-HCl, pH 7.4, and
whole homogenates prepared by sonication (14).
Biochemical Determinations
Hepatocyte whole homogenate and/or liver whole ho-
mogenate fractions were assayed for activities ofKCN-
insensitive palmitoyl-CoA oxidation, carnitine acetyl-
transferase, total and heat labile enoyl-CoA hydratase,
and protein content as described previously (14-16).
The activity of lauric acid hydroxylation (measured as
the combined 11- and 12-hydroxylation) in hepatocyte
whole homogenates was measured by the method of
Lake et al. (18). Liverwhole homogenate fractions were
also fractionated by differential centrifugation (16) to
obtainwashed microsomal fractionswhich were assayed
for content of cytochrome P-450 and protein and activ-
ities ofethylmorphine N-demethylase and 7-ethoxycou-
marin 0-deethylase (16). Microsomal lauric acid 11- and
12-hydroxylation was assayed as described previously
(16) but employing high performance liquid chromatog-
raphy to separate the two metabolites (9).
Results
Structure-Activity Studies
Rat hepatocytes were cultured for 70 hr with a series
of six phthalate monoesters and the activities of KCN-
insensitive palmitoyl-CoA oxidation and carnitine ace-
tyltransferase determined. Whereas the former enzyme
is a specific peroxisomal marker (8), carnitine acetyl-
transferase is located in peroxisomal, mitochondrial,
and microsomal fractions (19). However, unlike the spe-
cific mitochondrial marker carnitine palmitoyltransfer-
ase (20), carnitine acetyltransferase activityismarkedly
induced in rat primary hepatocyte cultures by anumber
ofperoxisome proliferators (14). Theadditionofmono(2-
ethylhexyl) phthalate (MEHP), which is the primary
metabolite of DEHP (13), produced dose-related in-
creasesinthe activities ofpalmitoyl-CoAoxidation (Fig.
1) and carnitine acetyltransferase (Fig. 2). MEHP was
more potent than either its one substituted isomer
mono(1-ethylhexyl) phthalate (MlEHP) or its straight-
chain isomer mono-n-octyl phthalate (MNOP). Similar
effects were obtained with the three hexyl isomers ex-
amined, where mono(2-ethylbutyl) phthalate (M2EBP)
was more potent than eithermono(1-ethylbutyl) phthal-
ate (MlEBP) or mono-n-hexyl phthalate (MNHP). In
general, the octyl isomers were more potent than the
hexyl isomers, as they stimulated enzyme activities at
lower concentrations in the culture medium. In order
to provide an expression of potency the concentrations
of the monoesters required to elicit a 3-fold (i.e., 300%
of control) increase in palmitoyl-CoA oxidation were
calculated. For the straight-chain, 1- and 2-ethyl-sub-
stituted octyl isomers the values were 201, 260, and 51
pLM; and for the straight-chain, 1- and 2-ethyl-substi-
tuted hexyl isomers the values were 508, 536, and 156
FtM. The hepatocyte culture studies would thus suggest
that MEHP may be a more potent inducer of peroxi-
somal enzyme activities invivothan MlEHP. The effect
ofadministration ofthese two compounds to youngmale
Sprague-Dawley rats for 7 days at oral dose levels of
50-500 mg/kg/day is shown in Figure 3. With both en-
zyme activities measured, dose-dependent effects were
observed, MEHPbeingthe morepotentinducerinvivo.
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We have also observed in vivo potency differences in
the induction of peroxisomal enzyme activities with
phthalate diesters. The hypolipidemic drug clofibrate,
DEHP, the straight-chain isomer of DEHP di-n-octyl
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URE 3. Effect of administration of phthalate monoesters on rat
hepatic palmitoyl-CoA oxidation (o, *) and carnitine acetyltrans-
ferase (A, A) activities. Rats were treated orally with 50-500 mg/
kg/day of either mono(1-ethylhexyl) phthalate (open symbols) or
mono(2-ethylhexyl) phthalate (closed symbols), for 7 days. All re-
sults are expressed as percentage of control (corn oil-treated) ac-
tivities and eachpointrepresents themean ± SEM offiveanimals.
MEHP /MIEBP phthalate (DNOP), and mono-n-octyl phthalate (MNOP)
-whichisthe primarymetabolite ofDNOP (21)-were
administered to young male Sprague-Dawley rats for
14 days. The dose levels of the phthalate esters were
Al /:7 oX SNHXequimolar. Although all four compounds increased the _I__I_EHP_ relative liver weight (i.e., liver weight/100 g body
weight) only DEHP and clofibrate produced large in-
creases in palmitoyl-CoA oxidation (Table 1). Similarly,
20 5'0 100 200 500 10'00 only DEHPand clofibrateincreasedtotal (mitochondrial
Phthalate Monoester(FM) and peroxisomal) and heat labile (peroxisomal) (22) en-
oyl-CoA hydratase activity.
FIGURE 2. Effect ofphthalate monoesters on carnitine acetyltrans-
ferase in primary rat hepatocytes. Cells were cultured for 70 hr
with either 20-200 ,uM of the octyl isomers (closed symbols),
namely, mono-n-octyl phthalate (MNOP), mono(l-ethylhexyl)
phthalate (MlEHP), and mono(2-ethylhexyl) phthalate (MEHP),
or 100-1000 ,uM of the hexyl isomers (open symbols), namely,
mono-n-hexyl phthalate (MNHP), mono(1-ethylbutyl) phthalate
(MlEBP), and mono(2-ethylbutyl) phthalate (M2EBP). All results
are expressed as percentage of control activities and each point
represents the mean of at least three experiments.
Species Difference Studies
Previous studies have demonstrated that species dif-
ferences exist in the response to the hepatic effects of
peroxisome proliferators (1). For example, clofibrate
has been reported to increase peroxisome numbers in
the rat but apparently not in the hamster (23). Accord-
ingly, we compared the effects of DEHP and MEHP in
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Table 1. Effect of oral administration of DEHP, DNOP, MNOP, and clofibrate on liver size and some hepatic parameters in the rat.
Compound and dose (mg/kg/day)a b
Control DEHP DNOP MNOP Clofibrate
Parameter (corn oil) (1000) (1000) (715) (500)
Relative liver weight, g liver/100 g body 3.6 ± 0.1 6.2 0.1* 4.2 ± 0.1* 4.3 ± 0.1* 6.1 ± 0.1*
wt.
Palmitoyl-CoA oxidationc 5.6 ± 0.3 28.3 + 1.3* 6.9 ± 0.5 7.9 ± 0.8 33.2 ± 0.8*
Enoyl-CoA hydratasec
Total activity 8.6 ± 0.4 29.1 ± 1.0* 8.6 ± 0.5 9.3 + 1.1 29.4 + 2.4*
Heat labile activity 1.6 ± 0.1 22.1 ± 0.9* 2.6 ± 0.3 3.9 ± 0.6 22.9 ± 2.4*
aRats were treated by daily gastric intubation for 14 days, the doses of the phthalate esters were equimolar.
bAll results are expressed as the means ± SEM for groups of six animals.
'In units of nmol/min/mg whole homogenate protein.
*Significantly different (Dunnett's test) from control, p < 0.01.
Sprague-Dawley rats and Syrian and Chinese hamsters.
For purposes of comparison studies were also under-
taken with clofibrate and/or clofibric acid which is the
primary deethylated metabolite of clofibrate (24).
The administration of DEHP, MEHP, and clofibrate
produced marked increases in liver size and activities
of palmitoyl-CoA oxidation and carnitine acetyltrans-
ferase in the rat (Table 2). In contrast, these three
compounds and clofibric acid produced little effect in
Syrian hamsters. However, Chinese hamsters were
more responsive than Syrian hamsters to the hepatic
effects of DEHP, MEHP, and clofibric acid (Table 2).
The species differences in induction of peroxisomal
enzyme activities observed in vivo could also be largely
reproduced in primary hepatocyte cultures. The culture
ofSprague-Dawley rat hepatocytes for70 hrwith either
20-200 FLM MEHP (Fig. 4) or 50-1000 FM clofibric acid
(Fig. 5) resulted in dose-dependent increases in pal-
mitoyl-CoA oxidation activity. In contrast, little effect
was observed in hepatocytes from either Syrian ham-
sters or Dunkin-Hartley guinea pigs. Previous studies
have indicated that the guinea pig may be refractory to
peroxisome proliferators as negative effects of both
DEHP (25) and clofibrate (23) have been reported in
this species.
The species difference observed in vivo between Syr-
ian and Chinese hamsters was also exhibited in cell cul-
ture. The culture of Chinese hamster hepatocytes for
70 hr with either MEHP, clofibric acid, or 4-chloro-6-
(2,3-xylidino)-2-pyrimidinylthio(N-,B-hydroxy-ethyl)-
acetamide (BR-931) resulted in significant increases in
palmitoyl-CoA oxidation activity (Table 3). BR-931 is
known to be a potent inducer of peroxisomal enzyme
activities both in vivo (2) and in vitro (14). In contrast
to the Chinese hamster, only clofibric acid produced a
significant increase in enzyme activity in hepatocytes
from Syrian hamsters.
Microsomal Effects of Phthalate Esters
and Related Compounds
The administration of DEHP and clofibrate, but not
DNOP, to male Sprague-Dawley rats resulted in small
increases in hepatic microsomal cytochrome P-450 con-
tent and activities ofethylmorphine N-demethylase and
7-ethoxycoumarin 0-deethylase (Fig. 6). However, both
DEHP and clofibrate administration produced amarked
induction of lauric acid hydroxylation and in particular
of the 12-hydroxylation (i.e., w-hydroxylation) of this
substrate. Increased lauric acid hydroxylation was also
Table 2. Effect of oral administration of DEHP, MEHP, clofibrate, and clofibric acid on liver size and some hepatic parameters in
the rat and two hamster species.
Compound and dose (mg/kg/day)ahb
DEHP MEHP Clofibrate Clofibric acid
Species Parameterc (1000) (500) (500) (250)
Sprague-Dawley rat RLW 176* 165* 190* n.d.'i
PCoA 1010* 1380* 1770* n.d.
CAT 1500* 2100* 1790* n.d.
Syrian hamster RLW 122* 10, 105 116*
PCoA 187* 1711, 175* 158*
CAT 197* 162* 251* 183t
Chinese hamster RLW 155* 138* n.d. 131*
PCoA 559* 359* n.d. 438*
CAT 265* 215* n.d. 313*
aAnimals were treated by daily gastric intubation for 14 days.
bAll results are expressed as percentage of control levels and are mean values for groups of three to six animals.
'The parameters measured were relative liver weight (RLW), palmitoyl-CoA oxidation (PCoA) and carnitine acetyltransferase (CAT).
(in.d., not determined.
*Significantly different (Dunnett's test) from control, p < 0.01.
t Significantly different (Dunnett's test) from control, p < 0.05.
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FIGURE 4. Effect of culture with 20-200 ,uM MEHP for 70 hr on
palmitoyl-CoA oxidation in primary hepatocyte cultures. All re-
sults are expressed as percentage ofcontrol activities forSprague-
Dawley rat (M) hepatocytes (left-hand y axis) and Syrian hamster
(M) and Dunkin-Hartley guinea pig (A) hepatocytes (right-hand y
axis, i.e., the expanded scale). Each point represents the mean of
at least three experiments.
observed after MEHP treatment (data not shown),
whereas DNOP and MNOP induced neither peroxiso-
mal (Table 1) normicrosomal (Fig. 6and datanotshown)
fatty acid oxidation.
Employing primary hepatocyte cultures we investi-
gated the relationship between the induction of per-
oxisomal and microsomal enzyme activities by a range
of ten hypolipidemic agents including three phthalate
monoesters, namely MEHP, MNOP and monoethyl
phthalate. Rat hepatocytes were cultured for 70 hrwith
the compounds and the activities of carnitine acetyl-
transferase, palmitoyl-CoA oxidation, lauric acid hy-
droxylation (measured as the combined 11- and 12-hy-
droxylation) and 7-ethoxycoumarin 0-deethylase
determined. The induction of carnitine acetyltransfer-
ase and lauric acid hydroxylation was highly correlated
(r = 0.980, p < 0.001) (Fig. 7), as was the induction of
palmitoyl-CoA oxidation and lauric acid hydroxylation
(r = 0.967, p < 0.001) (data not shown). In contrast,
the induction of either carnitine acetyltransferase (r =
-0.253, p > 0.05) or palmitoyl-CoA oxidation (r =
-0.156, p > 0.05) did not correlate with atypical mixed
function oxidase enzyme activity, namely 7-ethoxycou-
marin O-deethylase (data not shown).
Discussion
The structure activity studies indicated potency dif-
ferences between various phthalate esters. For exam-
Clofibric Acid(,M)
FIGURE 5. Effect of culture with 50-1000 FM clofibric acid for 70
hr on palmitoyl-CoA oxidation in primary hepatocyte cultures. All
results are expressed as percentage ofcontrol activities for Spra-
gue-Dawley rat (0) hepatocytes (left-hand y axis) and Syrian ham-
ster (U) and Dunkin-Hartley guinea pig (A) hepatocytes (right-
hand y axis, i.e., the expanded scale). Each point represents the
mean of at least three experiments.
ple, with a range of monoesters, octyl isomers were
generally more potent than hexyl isomers. Branched-
chain esters, depending onthe position ofthe side chain,
may be more potent than straight-chain esters. How-
ever, the observed differences in induction 'of. peroxi-
somal enzymes by phthalate esters appear, in general,
to be dose-related, and thus the observed differences
maybepurely quantitativeratherthanqualitative. Cer-
tainly, in the cell culture studies no compound was truly
negative, in that they all produced some stimulation of
enzyme activities. We have previously demonstrated
increases in peroxisome numbers in rat hepatocyte cul-
turesaftertreatment with MEHPand otherperoxisome
proliferators (14, 26, 27). Although hepatocyte cultures
cannot compensate for differences in compound phar-
Table 3. Effect of some peroxisome proliferators on palmitoyl-
CoA oxidation in Chinese and Syrian hamster hepatocyte
cultures.
Treatment (70 hr culture)T
MEHP Clofibric acid BR-931
Hamster (0.2mM) (0.5mM) (50,uM)
Chinese 361* 508* 502*
Syrian 119 117* 132
"All results are expressed as percentage of control levels and are
mean values for either three or four experiments.
* Significantly different (Dunnett's test) from control, p < 0.01.
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FIGURE 6. Effect oforal administration ofDEHP (1000mg/kg/day),
DNOP (1000mg/kg/day) and clofibrate (500mg/kg/day)for 14days
on some rat hepatic microsomal parameters. The activities mea-
sured were cytochrome P-450 content (P450), ethylmorphine N-
demethylase (ETM), 7-ethoxycoumarin O-deethylase (7EC), lauric
acid l1-hydroxylation (LA 11-OH), and lauric acid 12-hydroxyla-
tion (LA 12-OH). Allresultsareexpressed aspercentage ofcontrol
(corn oil treated) activities and each point represents the mean of
at least four animals. Results significantly different (Dunnett's
test) from control are, (*) p < 0.05.
macokinetics as well as possible differences between in
vivo and in vitro metabolism; the present studies indi-
cate the potential usefulness of cell cultures as a rapid
and economical screen for the induction ofperoxisomal
enzyme activities. Primary hepatocyte cultures also re-
duce the requirement for experimental animals. In this
study, MEHP was found to be more potent than
MlEHP in inducing peroxisomal enzymes eitherinvivo
or in vitro.
Species differences in the magnitude of induction of
peroxisomal enzyme activities were observed between
the rat and Syrian and Chinese hamsters. In the case
ofDEHPthe observed difference betweenthe Sprague-
Dawley rat and Syrian hamster may be partially at-
tributed to differences in rates of intestinal hydrolysis
to MEHP and subsequent absorption and excretion (15)
as well as to species differences in the subsequent me-
tabolism of MEHP (28). However, that the in vivo dif-
ferences between the rat and Chinese and Syrian ham-
sters could be largelyreproduced invitro, suggeststhat
intrahepatic factors are of major importance in deter-
mining species differences in response. As would be
expected from the in vivo studies, the induction ofpal-
mitoyl-CoA oxidation was observed in rat and Chinese
hamster hepatocytes after treatment with either
MEHP or clofibric acid. In contrast, Syrian hamster
hepatocytes responded only weakly to clofibric acid and
no significant effect was observed with either MEHP
or BR-931. These observations do not correlate well
with in vivo findings as Syrian hamsters do respond
weakly to MEHP (Table 2), and the potent peroxisome
proliferator BR-931 has been shown to produce a
marked effect in this species after dietary administra-
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FIGURE 7. Relationship between the induction of carnitine acetyl-
transferase and lauric acid hydroxylation by hypolipidemic agents
in primary rat hepatocytes. Cells were cultured for 70 hr with (1)
Wy-14,643 (50 ,M), (2) tiadenol (50 ,uM), (3) nafenopin (50 ,uM),
(4) BR-931 (50 puM), (5) clofibrate (0.5 mM), (6) MEHP (0.2 mM),
(7) monoethyl phthalate (0.2 mM), (8) mono-n-octyl phthalate (0.2
mM), (9) MDL 14,514 (50 puM), and (10) acetylsalicylic acid (2.5
mM) or with no treatment (control). Chemical names of the hy-
polipidemicagentsaregivenelsewhere (17). Eachpointrepresents
the mean of either six control or four treated dishes.
tion for a period of 6 weeks (29).
Although hepatic peroxisome proliferation has been
reported tooccurinprimatespeciesaswellasinrodents
(30), controversy exists as to whether this effect occurs
in man (1,2). Should further species difference studies
confirm a good correlation between the in vivo and in
vitro effects of peroxisome proliferators, then appro-
priate studies with human hepatocyte cultures may be
of great value in predicting the likely human response
to these compounds. Species differences could also be
employed to probe the proposed relationship between
peroxisome proliferation and hepatocarcinogenicity
(2,3), by performing long-term studies in species such
as the Syrian hamster which is less responsive than the
rat to compounds such as DEHP and clofibrate.
Both clofibrate and DEHP appear to induce similar
form(s) of rat hepatic microsomal cytochrome P-450
which have a high specificity for the hydroxylation of
lauric acid. This was indicated by the present studies
comparingeffectsonanumberofmixedfunctionoxidase
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activities and by other studies where spectrophotome-
tric and electrophoretic criteria were also employed
(16). These effects can also be reproduced in cell culture
as both clofibrate and MEHP have been shown to main-
tain hepatocyte cytochrome P-450 levels and to induce
lauric acid hydroxylation (17,18). The cell culture stud-
ies also indicated that with a range of hypolipidemic
agents, including phthalate monoesters, a close corre-
lation exists between the induction of peroxisomal and
microsomal enzyme activities. Whetherthe induction of
novel form(s) of cytochrome P-450 by peroxisome pro-
liferators is involved in the hepatotoxicity ofthese com-
pounds remains to be elucidated.
In conclusion, the results described in this paper gen-
erally demonstrate a good correlation between the in
vivo and in vitro hepatic effects ofphthalate esters and
related compounds. Thus the factor(s) responsible for
the initiation of peroxisome proliferation and induction
ofperoxisomal andmicrosomal enzyme activities appear
to be intrahepatic in nature and are retained in primary
hepatocyte cultures. Hepatocyte cultures may thus be
useful forfurtherstudies ontherelevance ofperoxisome
proliferation to man (e.g., for structure-activity and
species difference studies) and also for investigations
into the mechanism ofhepatotoxicity ofperoxisome pro-
liferators.
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